2024-513860-25-00招募中2 期
A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subjects with Advanced Solid Tumors
Glaxosmithkline Research & Development Limited, Glaxosmithkline Research & Development Limited21 个研究点 分布在 7 个国家目标入组 85 人开始时间: 2024年10月22日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 85
- 试验地点
- 21
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（18-64 Years, 65+ Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
EU GSK Clinical Trials Call Center
Scientific
Glaxosmithkline Research & Development Limited
研究点 (21)
Loading locations...
相似试验
招募中
1 期
A Study of BL-M09D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid TumorsNCT06954077Sichuan Baili Pharmaceutical Co., Ltd.45
终止
1 期
A first-in-human study of VG161 in participants with advanced malignant tumours that have not responded to conventional therapies.Advanced malignant solid tumorsCancer - Other cancer typesCancer - Any cancerACTRN12620000244909Virogin Biotech Australia Pty. Ltd.7
已完成
1 期
A Clinical Study to know the safety, pharmacokinetics and anticancer activity of NRC-2694-A in patients with advanced cancersCTRI/2014/01/004293ATCO Pharma Limited26
进行中（未招募）
1 期
A clinical trial to study the effect of NRC-AN-019 in patients with various cancers.CTRI/2009/091/000900ATCO Pharma Ltd
已完成
不适用
Phase I clinical study to evaluate the safety and tolerability of Quadrivalent Influenza Vaccine (QIV) delivered intradermally by a high-density micro-array patch (HD MAP), compared to intramuscular Influvac® Tetra injection, in healthy adults aged 18 to 50 yearsrespiratory infectionRespiratory - Other respiratory disorders / diseasesInfluenzaACTRN12622001203741Vaxxas Pty Ltd150